sur Quantum Biopharma Ltd.
Quantum BioPharma Files $700M Lawsuit Alleging Stock Price Manipulation
Quantum BioPharma Ltd., a biopharmaceutical company, has announced a lawsuit filed in the US District Court against CIBC World Markets, RBC Dominion Securities, and others. The company seeks over $700 million in damages for alleged stock price manipulation through "spoofing" techniques. This legal move follows an investigation by Christian Attar Law Firm and Freedman Normand Friedland LLP, revealing evidence of alleged market manipulation from January 2020 to August 2024.
The alleged practices reportedly caused Quantum's share price to plummet from over $460 to $7.55 per share, severely impacting the company's market value and its shareholders. The law firms, engaged on a contingency basis, have found sufficient grounds to support the claims.
The lawsuit underscores the company's commitment to shareholder equity and signals potential further actions against other unnamed entities involved in the alleged scheme.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Quantum Biopharma Ltd.